Xavier Taylor, PhD, is a Scientific Advisor specializing in neurodegeneration at Eli Lilly and Company, where they lead a discovery biology laboratory and design preclinical studies. Previously, they worked as a Postdoctoral Research Scientist at the same company, focusing on therapeutic development for neurodegenerative diseases. Xavier conducted graduate research at Indiana University School of Medicine, exploring the mechanisms of cerebral amyloid angiopathy and its role in neuroinflammation and neurodegeneration. They also gained valuable experience as an undergraduate researcher and have published several papers in prominent scientific journals. Xavier holds a Bachelor of Science in Neuroscience and a PhD in Medical Neuroscience from Indiana University.
This person is not in any teams
This person is not in any offices